Evidence map›Paper›PMID 29252117›Full record

ArticleHuman vaccines & immunotherapeutics2018

Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8

D Korenkov, T H O Nguyen, I Isakova-Sivak, T Smolonogina, L E Brown, K Kedzierska, L Rudenko

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

D Korenkova Department of Virology , Institute of Experimental Medicine , Saint Petersburg , Russia.
T H O Nguyenb Department of Microbiology & Immunology , University of Melbourne, at The Peter Doherty Institute for Infection & Immunity , Melbourne , VIC , Australia.
I Isakova-Sivaka Department of Virology , Institute of Experimental Medicine , Saint Petersburg , Russia.ORCID 0000-0002-2801-1508
T Smolonoginaa Department of Virology , Institute of Experimental Medicine , Saint Petersburg , Russia.
L E Brownb Department of Microbiology & Immunology , University of Melbourne, at The Peter Doherty Institute for Infection & Immunity , Melbourne , VIC , Australia.
K Kedzierskab Department of Microbiology & Immunology , University of Melbourne, at The Peter Doherty Institute for Infection & Immunity , Melbourne , VIC , Australia.
L Rudenkoa Department of Virology , Institute of Experimental Medicine , Saint Petersburg , Russia.
The University of Melbourne · AUInstitute of Experimental Medicine · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Live attenuated influenza vaccines (LAIV) induce CD8

Indexed as

Antibodies, ViralCD8-Positive T-LymphocytesCell Line, TumorEpitopes, T-LymphocyteHumansInfluenza A Virus, H3N2 SubtypeInfluenza, HumanInfluenza VaccinesNucleoproteinsRussiaVaccines, AttenuatedAntibodies, ViralEpitopes, T-LymphocyteInfluenza VaccinesNucleoproteinsVaccines, AttenuatedAntigenic escapeinfluenzaLAIVnucleoproteinT cell epitope

Identifiers

PMID29252117
PMCPMC5893192
OpenAlexW2779115643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.